Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
article

Manufacturing, Packaging & Logistics In-Depth Focus 2021

Download this in-depth focus to learn about how the logistics industry rose to the challenge of the COVID-19 vaccine rollout and the complexities of the production process for plasma derived therapies.

Manufacturing, Packaging & Logistics

    To read this in-depth focus in full, please complete the form below:

     









    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    • COVID-19 vaccine rollout: a logistics success story
      The dedication of the science community and healthcare workers in the fight against COVID-19 has been unwavering and justly praised. Yet logistics workers and the industries that support it have also achieved tremendous feats to support the resulting aid. Here, Zoe McLernon, Multimodal Policy Manager at Logistics UK, highlights the efforts involved in coordinating the vaccine rollout.
    • Plasma-derived therapies require a mastery of advanced bioproduction techniques
      Plasma-derived therapies and medicines provide life-changing treatments for patients around the world who suffer from serious, and often rare, diseases that affect the immune system or result from non-functioning proteins in blood plasma. Carole Resman, Executive Vice President Production at LFB, describes the complex and highly regulated manufacturing process of these unique biological medicines.